BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12218578)

  • 1. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.
    Taniere P; Borghi-Scoazec G; Saurin JC; Lombard-Bohas C; Boulez J; Berger F; Hainaut P; Scoazec JY
    Am J Surg Pathol; 2002 Sep; 26(9):1213-21. PubMed ID: 12218578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
    Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
    Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.
    Driessen A; Nafteux P; Lerut T; Van Raemdonck D; De Leyn P; Filez L; Penninckx F; Geboes K; Ectors N
    Mod Pathol; 2004 Jan; 17(1):49-55. PubMed ID: 14631371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
    Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
    Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.
    Rüdiger Siewert J; Feith M; Werner M; Stein HJ
    Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
    Sarbia M; Borchard F; Hengels KJ
    Pathol Res Pract; 1993 Jun; 189(5):530-5. PubMed ID: 7690953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
    Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
    Siewert JR; Feith M
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adenocarcinoma of the gastro-esophageal junction].
    Huang Q; Fan XS; Shi J; Zhang YF; Feng AN; Wu HY; Sun Q; Zhou Q; Yu HP; Meng FQ; Wang JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):793-5. PubMed ID: 23324225
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction.
    Dislich B; Kröll D; Langer R
    Updates Surg; 2023 Feb; 75(2):395-402. PubMed ID: 36001283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.
    Moskaluk CA; Heitmiller R; Zahurak M; Schwab D; Sidransky D; Hamilton SR
    Hum Pathol; 1996 Nov; 27(11):1211-20. PubMed ID: 8912833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.
    Hamilton SR; Smith RR; Cameron JL
    Hum Pathol; 1988 Aug; 19(8):942-8. PubMed ID: 3402983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I; Tzardi M; Mouzas IA; Micev M; Pesko P; Milosavljevic T; Zois M; Sganzos M; Delides G; Kanavaros P
    Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.